RTX Healthcare receives FDA approval of its Wireless Telehealth Gateway  

The US based subsidiary of RTX Telecom has gained a preliminary FDA approval which means the wireless device can be marketed

RTX Healthcare, a US based subsidiary of the Jutland based RTX Telecom, has gained preliminary approval from the US Food and Drug Administration (FDA) for its Wireless Telehealth Gateway. It means that the small device now can be marketed in the US. The wireless Bluetooth device has been designed for home health monitoring.


Chris Tubis, CEO of RTX America says the wireless Telehealth Gateway is the first FDA approved connectivity device for remote patient monitoring, filling what has been a missing link between standard wireless patient monitors and electronic health records. The purpose of the Gateway is to transmit selected medical information such as weight and blood pressure over a normal residential telephone line directly to a healthcare facility. The device is not connected to or operated by the patient.


RTX Telecom is headquartered in Norresundby, north Jutland and specialises in the development of advanced wireless communication solutions across the entire range of wireless communication standards including GSM/GPRS, Bluetooth and VoIP. In 2004, RTX Telecom established a US subsidiary in San José, California under the name RTX America, Inc. The news is reported by professional journal Ingeniøren (the Engineer) and on RTX Telecom's website.


Link > RTX Telecom 

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×